These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 1808871

  • 21. The influence of nifedipine (Corinfar) on pulmonary hypertension in chronic obstructive lung disease.
    Schauer J, Orschekowski H, Steiniger L, Winkler J, Schilling W, Harzbecker K, Evers H.
    Z Erkr Atmungsorgane; 1990; 175(3):132-40. PubMed ID: 2127872
    [Abstract] [Full Text] [Related]

  • 22. Influence of ACE inhibition on pulmonary haemodynamics and function in patients in whom beta-blockers are contraindicated.
    Bertoli L, Fusco M, Lo Cicero S, Micallef E, Busnardo I.
    Postgrad Med J; 1986; 62 Suppl 1():47-51. PubMed ID: 3022273
    [Abstract] [Full Text] [Related]

  • 23. Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil.
    Adnot S, Samoyeau R, Weitzenblum E.
    Blood Press Suppl; 1995; 3():47-57. PubMed ID: 8535542
    [Abstract] [Full Text] [Related]

  • 24. [Clinical interpretation for the pressure-flow relationships in extrinsic allergic alveolitis and in interstitial lung disease pulmonary hypertension patients. Should we care for the lung, the pulmonary artery pressure or both?].
    Lupi-Herrera E, Santos-Martínez LE, Pulido T, Sandoval J.
    Arch Cardiol Mex; 2009; 79(2):91-103. PubMed ID: 19722378
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Pharmacokinetics of trapidil (Rocornal) in patients with chronic liver disease.
    Berndt A, Pönicke K, Weiss M.
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):492-3. PubMed ID: 1490801
    [Abstract] [Full Text] [Related]

  • 27. The effect of amlodipine on exercise-induced pulmonary hypertension and right heart function in patients with chronic obstructive pulmonary disease.
    Franz IW, Van Der Meyden J, Schaupp S, Tönnesmann U.
    Z Kardiol; 2002 Oct; 91(10):833-9. PubMed ID: 12395224
    [Abstract] [Full Text] [Related]

  • 28. Nitroglycerin and isosorbide dinitrate in pulmonary hypertension of chronic obstructive pulmonary disease.
    Delaunois L, Jonard P, Kremer N, Dubois P, Lulling J.
    Bull Eur Physiopathol Respir; 1984 Oct; 20(1):11-8. PubMed ID: 6423015
    [Abstract] [Full Text] [Related]

  • 29. [A study on pulmonary hemodynamic in patients with stable chronic obstructive pulmonary disease].
    Zhang ZX.
    Zhonghua Jie He He Hu Xi Za Zhi; 1991 Oct; 14(5):273-5, 318. PubMed ID: 1819378
    [Abstract] [Full Text] [Related]

  • 30. [Severe obstructive lung disease. The effect of the calcium antagonist isradipine on working capacity, pulmonary function, morbidity and survival].
    Petersen JR, Galløe AM, Graudal NA, Galløe M.
    Ugeskr Laeger; 1993 Aug 23; 155(34):2612-5. PubMed ID: 8212369
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Long-term treatment of chronic obstructive lung disease by Nifedipine: an 18-month haemodynamic study.
    Saadjian AY, Philip-Joet FF, Vestri R, Arnaud AG.
    Eur Respir J; 1988 Aug 23; 1(8):716-20. PubMed ID: 3069486
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Aldactone therapy in ambulatory patients with exertion-induced cardiorespiratory insufficiency. Preliminary report].
    Braun I.
    Wien Med Wochenschr; 1976 Oct 22; 126(42-44):620-4. PubMed ID: 997581
    [No Abstract] [Full Text] [Related]

  • 37. [Effects of nifedipine in patients with chronic obstructive bronchitis and pulmonary hypertension undergoing artificial respiration].
    Turetta F, De Stefani R, Milanesi A, Cannizzaro A, Stievano N, Bossi A, Simone M.
    Ann Fr Anesth Reanim; 1989 Oct 22; 8(3):267-72. PubMed ID: 2675691
    [Abstract] [Full Text] [Related]

  • 38. Short- and long-term hemodynamic effects of oral nifedipine in patients with pulmonary hypertension secondary to COPD and lung fibrosis. Deleterious effects in patients with restrictive disease.
    Domenighetti GM, Saglini VG.
    Chest; 1992 Sep 22; 102(3):708-14. PubMed ID: 1516391
    [Abstract] [Full Text] [Related]

  • 39. Relationship between oxygen uptake and oxygen transport in stable patients with chronic obstructive pulmonary disease. Physiologic effects of nitroprusside and hydralazine.
    Brent BN, Matthay RA, Mahler DA, Berger HJ, Zaret BL, Lister G.
    Am Rev Respir Dis; 1984 May 22; 129(5):682-6. PubMed ID: 6721268
    [Abstract] [Full Text] [Related]

  • 40. Dehydroepiandrosterone (DHEA) improves pulmonary hypertension in chronic obstructive pulmonary disease (COPD): a pilot study.
    Dumas de La Roque E, Savineau JP, Metivier AC, Billes MA, Kraemer JP, Doutreleau S, Jougon J, Marthan R, Moore N, Fayon M, Baulieu EÉ, Dromer C.
    Ann Endocrinol (Paris); 2012 Feb 22; 73(1):20-5. PubMed ID: 22280813
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.